BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND PTPRC, LCA, 5788, ENSG00000081237, T200, GP180, B220, LY5, CD45 AND Treatment
45 results:

  • 1. A Microfluidics Approach for Ovarian cancer Immune Monitoring in an Outpatient Setting.
    Libbrecht S; Vankerckhoven A; de Wijs K; Baert T; Thirion G; Vandenbrande K; Van Gorp T; Timmerman D; Coosemans A; Lagae L
    Cells; 2023 Dec; 13(1):. PubMed ID: 38201211
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
    Zhao S; Li Y; Xu J; Shen L
    Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Identification of two immune subtypes and four hub immune-related genes in ovarian cancer through multiple analysis.
    Tang Q; Zhang H; Tang R
    Medicine (Baltimore); 2023 Oct; 102(40):e35246. PubMed ID: 37800814
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Nanoscale CAR Organization at the Immune Synapse Correlates with CAR-T Effector Functions.
    Sajman J; Yakovian O; Unger Deshet N; Almog S; Horn G; Waks T; Globerson Levin A; Sherman E
    Cells; 2023 Sep; 12(18):. PubMed ID: 37759484
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Identifying patient profiles of disparate care in resectable pancreas cancer using latent class analysis.
    Maduekwe UN; Stephenson BJK; Yeh JJ; Troester MA; Sanoff HK
    J Surg Oncol; 2023 Aug; 128(2):254-261. PubMed ID: 37095707
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Fusion Cell Markers in Circulating Tumor Cells from Patients with High-Grade Ovarian Serous Carcinoma.
    Ruano APC; Gadelha Guimarães AP; Braun AC; Flores BCTCP; Tariki MS; Abdallah EA; Torres JA; Nunes DN; Tirapelli B; de Lima VCC; Fanelli MF; Colombo PE; da Costa AABA; Alix-Panabières C; Chinen LTD
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499015
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. EMT Molecular Signatures of Pancreatic Neuroendocrine Neoplasms.
    Venugopal A; Michalczyk A; Khasraw M; Ackland ML
    Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362433
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Nonhematogenic circulating aneuploid cells confer inferior prognosis and therapeutic resistance in gliomas.
    Li M; Gao F; Ren X; Dong G; Chen H; Lin AY; Wang DD; Liu M; Lin PP; Shen S; Jiang H; Yang C; Zhang X; Zhao X; Zhu Q; Li M; Cui Y; Lin S
    Cancer Sci; 2022 Oct; 113(10):3535-3546. PubMed ID: 35940591
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Correlation between drug sensitivity profiles of circulating tumour cell-derived organoids and clinical treatment response in patients with pancreatic ductal adenocarcinoma.
    Wu YH; Hung YP; Chiu NC; Lee RC; Li CP; Chao Y; Shyr YM; Wang SE; Chen SC; Lin SH; Chen YH; Kang YM; Hsu SM; Yen SH; Wu JY; Lee KD; Tseng HE; Tsai JR; Tang JH; Chiou JF; Burnouf T; Chen YJ; Wang PY; Lu LS
    Eur J Cancer; 2022 May; 166():208-218. PubMed ID: 35306319
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Identification of Claudin 6-specific HLA class I- and HLA class II-restricted T cell receptors for cellular immunotherapy in ovarian cancer.
    Matsuzaki J; Lele S; Odunsi K; Tsuji T
    Oncoimmunology; 2022; 11(1):2020983. PubMed ID: 35003898
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The Future of Somatostatin Receptor Ligands in Acromegaly.
    Gadelha MR; Wildemberg LE; Kasuki L
    J Clin Endocrinol Metab; 2022 Jan; 107(2):297-308. PubMed ID: 34618894
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Prognostic and Clinical Value of Interleukin 6 and cd45
    Wertel I; Suszczyk D; Pawłowska A; Bilska M; Chudzik A; Skiba W; Paduch R; Kotarski J
    J Immunol Res; 2020; 2020():1715064. PubMed ID: 33062717
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. BTN3A1 governs antitumor responses by coordinating αβ and γδ T cells.
    Payne KK; Mine JA; Biswas S; Chaurio RA; Perales-Puchalt A; Anadon CM; Costich TL; Harro CM; Walrath J; Ming Q; Tcyganov E; Buras AL; Rigolizzo KE; Mandal G; Lajoie J; Ophir M; Tchou J; Marchion D; Luca VC; Bobrowicz P; McLaughlin B; Eskiocak U; Schmidt M; Cubillos-Ruiz JR; Rodriguez PC; Gabrilovich DI; Conejo-Garcia JR
    Science; 2020 Aug; 369(6506):942-949. PubMed ID: 32820120
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Antibody Supervised Training of a Deep Learning Based Algorithm for Leukocyte Segmentation in Papillary Thyroid Carcinoma.
    Stenman S; Bychkov D; Kucukel H; Linder N; Haglund C; Arola J; Lundin J
    IEEE J Biomed Health Inform; 2021 Feb; 25(2):422-428. PubMed ID: 32750899
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Immunocyte density in parathyroid carcinoma is correlated with disease relapse.
    Hu Y; Cui M; Bi Y; Zhang X; Wang M; Hua S; Liao Q; Zhao Y
    J Endocrinol Invest; 2020 Oct; 43(10):1453-1461. PubMed ID: 32219691
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Non-clinical efficacy, safety and stable clinical cell processing of induced pluripotent stem cell-derived anti-glypican-3 chimeric antigen receptor-expressing natural killer/innate lymphoid cells.
    Ueda T; Kumagai A; Iriguchi S; Yasui Y; Miyasaka T; Nakagoshi K; Nakane K; Saito K; Takahashi M; Sasaki A; Yoshida S; Takasu N; Seno H; Uemura Y; Tamada K; Nakatsura T; Kaneko S
    Cancer Sci; 2020 May; 111(5):1478-1490. PubMed ID: 32133731
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Single-cell RNA sequencing reveals compartmental remodeling of tumor-infiltrating immune cells induced by anti-CD47 targeting in pancreatic cancer.
    Pan Y; Lu F; Fei Q; Yu X; Xiong P; Yu X; Dang Y; Hou Z; Lin W; Lin X; Zhang Z; Pan M; Huang H
    J Hematol Oncol; 2019 Nov; 12(1):124. PubMed ID: 31771616
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Increased cytoplasmatic expression of cancer immune surveillance receptor CD1d in anaplastic thyroid carcinomas.
    Weber F; Junger H; Werner JM; Velez Char N; Rejas C; Schlitt HJ; Hornung M
    Cancer Med; 2019 Nov; 8(16):7065-7073. PubMed ID: 31560833
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Identification of potential core genes and miRNAs in testicular seminoma via bioinformatics analysis.
    Wang K; Chen Y; Zhao Z; Feng M; Zhang S
    Mol Med Rep; 2019 Nov; 20(5):4013-4022. PubMed ID: 31545448
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Detection of Abundant Non-Haematopoietic Circulating cancer-Related Cells in Patients with Advanced Epithelial Ovarian cancer.
    Kumar J; Chudasama D; Roberts C; Kubista M; Sjöback R; Chatterjee J; Anikin V; Karteris E; Hall M
    Cells; 2019 Jul; 8(7):. PubMed ID: 31319587
    [No Abstract]    [Full Text] [Related]  


    [Next]

    of 3.